154 related articles for article (PubMed ID: 37219654)
1. A Multi-institutional Analysis of the Combined Effect of Micropapillary Component and Consolidation-to-Tumor Ratio >0.5 on the Prognosis of Pathological, Stage IA3, Lung Adenocarcinoma.
Xu SJ; Tu JH; Chen H; Yan RH; Chen RQ; Chen C; You CX; Zhang ZF; Yu SB; Chen SC
Ann Surg Oncol; 2023 Sep; 30(9):5843-5853. PubMed ID: 37219654
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Analysis of the Impact of Micropapillary Component on Different Recurrence Patterns of Pathological Stage IA3 Lung Adenocarcinoma: A Multicenter, Retrospective Study.
Xu SJ; Chen C; Tu JH; You CX; Chen RQ; Zhang ZF; Chen SC
Ann Surg Oncol; 2024 Feb; 31(2):872-882. PubMed ID: 37962740
[TBL] [Abstract][Full Text] [Related]
3. Effects of a ground-glass opacity component on the recurrence and survival of pathological stage IA3 lung adenocarcinoma: a multi-institutional retrospective study.
Xu SJ; Chen RQ; Tu JH; You CX; Chen C; Zhang ZF; Divisi D; Migliore M; Bongiolatti S; Durand M; Sato M; Kuroda H; Yang CF; Yu SB; Chen SC
Transl Lung Cancer Res; 2023 May; 12(5):1078-1092. PubMed ID: 37323166
[TBL] [Abstract][Full Text] [Related]
4. Predictive Value of Recurrence of Solid and Micropapillary Subtypes in Lung Adenocarcinoma.
Motono N; Mizoguchi T; Ishikawa M; Iwai S; Iijima Y; Uramoto H
Oncology; 2024; 102(4):366-373. PubMed ID: 37899040
[TBL] [Abstract][Full Text] [Related]
5. Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomy.
Wang Y; Zheng D; Zheng J; Huang Q; Han B; Zhang J; Zhao H; Chen H
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1015-1023. PubMed ID: 29532227
[TBL] [Abstract][Full Text] [Related]
6. Does the presence of a micropapillary component predict worse prognosis in pathological stage IA lung adenocarcinoma?
Wang Y; Song W; Wang X; Che G
Pathol Res Pract; 2023 Feb; 242():154314. PubMed ID: 36706587
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of the Maximum Standardized Uptake Value on the Prognosis of Clinical Stage IA Lung Adenocarcinoma Based on the 8th Edition TNM Classification.
Shigefuku S; Ito H; Miura J; Kikuchi A; Isaka T; Adachi H; Nakayama H; Ikeda N
Ann Surg Oncol; 2023 Feb; 30(2):830-838. PubMed ID: 36282457
[TBL] [Abstract][Full Text] [Related]
8. Impact of the micropapillary component on the timing of recurrence in patients with resected lung adenocarcinoma.
Watanabe K; Sakamaki K; Ito H; Yokose T; Yamada K; Nakayama H; Masuda M
Eur J Cardiothorac Surg; 2020 Nov; 58(5):1010-1018. PubMed ID: 32386405
[TBL] [Abstract][Full Text] [Related]
9. Lymph node metastasis risk factors in clinical stage IA3 lung adenocarcinoma.
Zheng Y; Ju S; Huang R; Zhao J
J Cancer Res Ther; 2023 Feb; 19(1):34-38. PubMed ID: 37006040
[TBL] [Abstract][Full Text] [Related]
10. [Association between the presence of solid or micropapillary components and survival outcome in stage ⅠA lung adenocarcinoma cases: a retrospective cohort study].
Jin KQ; Shen YR; Wu YM; Dai J; Liu XG; Li JQ; Chen LS; Jiang GN
Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):587-592. PubMed ID: 35658347
[No Abstract] [Full Text] [Related]
11. Establishment and validation of a nomogram model for predicting postoperative recurrence-free survival in stage IA3 lung adenocarcinoma: a retrospective cohort study.
Yu S; You C; Yan R; Chen H; Chen C; Xu S; Gonzalez M; Chen R; Kang M; Chen S
Transl Lung Cancer Res; 2022 Nov; 11(11):2275-2288. PubMed ID: 36519020
[TBL] [Abstract][Full Text] [Related]
12. [Validation of prognostic value of pathological staging in pathological stage Ⅰ lung adenocarcinoma].
Zhang H; Sun FH; Chen ZC; Wang Q
Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):580-586. PubMed ID: 35658346
[No Abstract] [Full Text] [Related]
13. Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size.
Chen C; Fu S; Ni Q; Yiyang W; Pan X; Jing J; Zhao H; Rui W
Med Sci Monit; 2019 Nov; 25():9003-9011. PubMed ID: 31772147
[TBL] [Abstract][Full Text] [Related]
14. Expansion of the Concept of Micropapillary Adenocarcinoma to Include a Newly Recognized Filigree Pattern as Well as the Classical Pattern Based on 1468 Stage I Lung Adenocarcinomas.
Emoto K; Eguchi T; Tan KS; Takahashi Y; Aly RG; Rekhtman N; Travis WD; Adusumilli PS
J Thorac Oncol; 2019 Nov; 14(11):1948-1961. PubMed ID: 31352072
[TBL] [Abstract][Full Text] [Related]
15. Micropapillary and Solid Histologic Patterns in N1 and N2 Lymph Node Metastases Are Independent Factors of Poor Prognosis in Patients With Stages II to III Lung Adenocarcinoma.
Li Y; Byun AJ; Choe JK; Lu S; Restle D; Eguchi T; Tan KS; Saini J; Huang J; Rocco G; Jones DR; Travis WD; Adusumilli PS
J Thorac Oncol; 2023 May; 18(5):608-619. PubMed ID: 36681298
[TBL] [Abstract][Full Text] [Related]
16. Which will carry more weight when CTR > 0.5, solid component size, CTR, tumor size or SUVmax?
Zhang S; Lin D; Yu Y; Cao Q; Liu G; Jiang D; Wang H; Fang Y; Shen Y; Yin J; Hou Y; Shi H; Ge D; Wang Q; Tan L
Lung Cancer; 2022 Feb; 164():14-22. PubMed ID: 34974221
[TBL] [Abstract][Full Text] [Related]
17. Relationship of Lymph Node Micrometastasis and Micropapillary Component and Their Joint Influence on Prognosis of Patients With Stage I Lung Adenocarcinoma.
Dai C; Xie H; Kadeer X; Su H; Xie D; Ren Y; She Y; Zhu E; Fan Z; Chen T; Qin L; Zheng H; Zhang L; Jiang G; Wu C; Chen C
Am J Surg Pathol; 2017 Sep; 41(9):1212-1220. PubMed ID: 28692600
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Study of Surgical Treated Lung Adenocarcinoma with Ground Glass Nodule Component.
Xu Y; Zheng M; Wang N; Wang R
Med Sci Monit; 2019 Nov; 25():8492-8498. PubMed ID: 31710020
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
